AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medinice S.A.

Regulatory Filings • Mar 7, 2025

5706_rns_2025-03-07_93c506fd-2291-44bd-96f1-49c3f1411256.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

Report Content The Management Board of MEDINICE S.A., headquartered in Warsaw (the"Company"), announces that on March 7, 2025, it received informationelectronically from the Management Board of the Mazovian Voivodeshipregarding the adoption of a resolution approving the evaluation resultsof the Company's application for funding under the European FundsProgram for Mazovia 2021-2027. The application falls under the Priority- European Funds for a More Competitive and Intelligent Mazovia, Action- Research, Development, and Innovation for Enterprises, with the callnumber:FEMA.01.01-IP.01-013/24

As a result of an independent evaluation conducted by the ProjectEvaluation Committee (KOP), theAtriClampproject received a positive assessment in both access criteria andgeneral substantive criteria. Consequently, the project, titled"AtriClamp- an innovative system for left atrial appendage occlusion (LAAO),"has been selected for funding in the amount ofPLN8,707,055.